Panayiotis Mavroidis, PhD

To quantify the impact of daily MR-guided adaptive replanning for prostate SBRT on protocol dose-constraint fulfillment, compared with non-adapted reference SBRT plans recalculated on daily anatomy, using both constraint-level pass/fail classification and the...

To investigate treatment plan quality of head and neck cancers via tumor control and normal tissue complications probability (TCP and NTCP) objectives in the plan optimization process.

Stereotactic body radiation therapy (SBRT) has been shown to be an effective treatment for hepatocellular carcinoma associated with lower rates of severe toxicity because of treatment. However, SBRT for liver carcinoma can still cause symptoms that may be ass...

To examine whether new recently reported dose volume constraints of bladder and rectum can be satisfied in clinical prostate CyberKnife SBRTs without sacrificing target coverage. Also, to use a normal tissue complication (NTCP) model to determine the expected...

To determine which cardiac substructures are associated with radiation-induced cardiac symptoms following radiotherapy for stage III non-small cell lung cancer (NSCLC), and to estimate the corresponding dose–response relationships using a widely applied norma...

Daily anatomical changes can invalidate the geometric, dosimetric, and biological assumptions of reference treatment plans. Quantitative evidence describing fraction-level deviations across disease sites remains limited, and adaptive workflows are often drive...